Early-Onset Appendiceal Cancer: Better Outcomes but Different Biology: Journal of Gastrointestinal Cancer | June 2026

• Early-onset appendiceal cancer, defined as diagnosis before age 50, accounts for nearly one-third of appendiceal malignancies.

• This NCDB analysis included more than 27,000 patients with appendiceal adenocarcinoma or neuroendocrine tumors diagnosed between 2005 and 2019.

• Early-onset appendiceal cancer patients were more often female, Hispanic, and privately insured compared with late-onset patients.

• The early-onset group had more favorable tumor biology, with a higher proportion of neuroendocrine tumors, low-grade disease, and stage I cancers.

• Stage I disease was almost twice as common in early-onset patients compared with late-onset patients.

• Early-onset patients were more frequently treated with appendectomy and minimally invasive surgery.

• They were less likely to undergo hemicolectomy or receive chemotherapy, reflecting earlier stage and more favorable histology.

• Five-year overall survival was significantly better in early-onset appendiceal cancer compared with late-onset disease.

• Survival advantage was seen across histologic subtypes and disease stages.

• Early-onset patients also had better perioperative outcomes, including shorter hospital stay, fewer positive margins, lower 30- and 90-day mortality, and fewer unplanned readmissions.

• The better survival should not be interpreted as age alone being protective; it likely reflects differences in tumor type, grade, stage, insurance status, and treatment patterns.

• The study highlights that appendiceal cancer in younger patients is biologically and clinically distinct from late-onset disease.

• Clinicians should avoid assuming that all early-onset gastrointestinal cancers behave aggressively; appendiceal cancer appears to follow a different pattern.

• However, because early-onset appendiceal cancer still represents a substantial proportion of cases, awareness and appropriate staging remain important.

Bottom line: Early-onset appendiceal cancer has better survival than late-onset disease, largely because it is more often neuroendocrine, low grade, early stage, and treated with less extensive surgery.